These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1921727)

  • 21. Changing patterns of psychoactive drug use with the mentally retarded.
    White AJ
    N Z Med J; 1983 Sep; 96(739):686-8. PubMed ID: 6577342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
    Clarke DJ; Kelley S; Thinn K; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishing socially validated drug research in community settings.
    Agran M; Martin JE
    Psychopharmacol Bull; 1985; 21(2):285-90. PubMed ID: 3889971
    [No Abstract]   [Full Text] [Related]  

  • 24. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot study on the use of psychotropic medication in persons with mental retardation.
    Radouco-Thomas M; Bolduc M; Brisson A; Brassard P; Fortier L; Thivierge J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):879-83. PubMed ID: 15363610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
    Grolleau A; Cougnard A; Bégaud B; Verdoux H
    Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in antiepileptic drug prescribing patterns in large institutions: preliminary results of a five-year experience.
    Poindexter AR; Berglund JA; Kolstoe PD
    Am J Ment Retard; 1993; 98 Suppl():34-40. PubMed ID: 8352920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
    Thinn K; Clarke DJ; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment.
    Connor DF; Ozbayrak KR; Harrison RJ; Melloni RH
    J Child Adolesc Psychopharmacol; 1998; 8(1):27-38. PubMed ID: 9639077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in psychotropic drug use in long-term residents of an ICF/MR facility.
    Hancock RD; Weber SL; Kaza R; Her KS
    Am J Ment Retard; 1991 Sep; 96(2):137-41. PubMed ID: 1681829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related pattern of the antiepileptic drug utilization in active epilepsy: a population-based survey.
    Bielen I; Sruk A; Planjar-Prvan M; Cvitanović-Sojat L; Kosicek M; Bergman-Marković B; Baraba R; Butković-Soldo S
    Coll Antropol; 2009 Jun; 33(2):659-63. PubMed ID: 19662794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
    Sarma S; Basu K; Gupta A
    Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practitioner review: Psychopharmacology in children and adolescents with mental retardation.
    Handen BL; Gilchrist R
    J Child Psychol Psychiatry; 2006 Sep; 47(9):871-82. PubMed ID: 16930381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in mental health services for people with intellectual disability in residential care in Israel 1998-2004.
    Merrick J; Kandel I; Stawski M
    Isr J Psychiatry Relat Sci; 2006; 43(4):281-4. PubMed ID: 17338448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
    Kanner AM; Gidal BE
    Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of epilepsy in a mentally retarded population: lack of correlation with IQ, neurological status, and electroencephalogram.
    Marcus JC
    Am J Ment Retard; 1993; 98 Suppl():47-51. PubMed ID: 8352922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of psychotropic drugs in mentally handicapped adults].
    Meins W
    Psychiatr Prax; 1988 Nov; 15(6):218-22. PubMed ID: 3237896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appropriate and inappropriate use of psychotherapeutic medications for institutionalized mentally retarded persons.
    Bates WJ; Smeltzer DJ; Arnoczky SM
    Am J Ment Defic; 1986 Jan; 90(4):363-70. PubMed ID: 3946473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.